Repligen (RGEN) PT Raised to $200 at UBS on Bioprocessing Recovery

January 16, 2026 9:22 AM EST Send to a Friend
(Updated - January 16, 2026 9:37 AM EST)

UBS analyst Elizabeth Garcia raised the price target on Repligen (NASDAQ ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login